These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25704326)
1. Vascular function and cardiovascular risk factors in women with severe flushing. Sassarini J; Lumsden MA Maturitas; 2015 Apr; 80(4):379-83. PubMed ID: 25704326 [TBL] [Abstract][Full Text] [Related]
2. Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis. Muka T; Oliver-Williams C; Colpani V; Kunutsor S; Chowdhury S; Chowdhury R; Kavousi M; Franco OH PLoS One; 2016; 11(6):e0157417. PubMed ID: 27315068 [TBL] [Abstract][Full Text] [Related]
3. The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk. Allison MA; Manson JE Menopause; 2009; 16(4):619-20. PubMed ID: 19503007 [No Abstract] [Full Text] [Related]
4. Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women. Harrington LB; Blondon M; Cushman M; Kaunitz AM; Allison MA; Wang L; Sullivan S; Woods NF; LaCroix AZ; Heckbert SR; McKnight B; Rossouw J; Smith NL J Thromb Haemost; 2018 May; 16(5):886-892. PubMed ID: 29504242 [TBL] [Abstract][Full Text] [Related]
5. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S; Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137 [TBL] [Abstract][Full Text] [Related]
6. Vasomotor symptoms and cardiovascular risk. Gambacciani M; Pepe A Climacteric; 2009; 12 Suppl 1():32-5. PubMed ID: 19811238 [TBL] [Abstract][Full Text] [Related]
7. Vasomotor symptoms and cardiovascular disease risk. Pines A Climacteric; 2011 Oct; 14(5):535-6. PubMed ID: 21848496 [TBL] [Abstract][Full Text] [Related]
8. Vasomotor flushes in menopausal women. Bachmann GA Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S312-6. PubMed ID: 10076170 [TBL] [Abstract][Full Text] [Related]
9. MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women. Stovall DW; Pinkerton JV Curr Opin Investig Drugs; 2009 Apr; 10(4):365-71. PubMed ID: 19337958 [TBL] [Abstract][Full Text] [Related]
10. Menopausal hot flushes and night sweats: where are we now? Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495 [TBL] [Abstract][Full Text] [Related]
11. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study. Ruiz AD; Daniels KR Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343 [TBL] [Abstract][Full Text] [Related]
12. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Utian WH Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502 [TBL] [Abstract][Full Text] [Related]